TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 6 | -1 | -1 | 0 | -23 | -58 | -65 | -25 |
| S | %wins | 67 | 67 | 50 | 50 | 100 | 100 | 72 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/13 16:26 | 8/13/13 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Berger Harvey J M D | MA | DO | CB,CEO | S.m | -2,177 | 18.34 | 33 | -119 | -3 | 3,472 | M | 106 | -5 | -9 | 7 | -5 | -7 | -5 | -1 | -2 | -5 | 14 | -86 | -52 | -68 |
7/18/13 16:21 | 7/16/13 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Berger Harvey J M D | MA | DO | CB,CEO | S.m | -3,957 | 19.84 | 33 | -199 | -5 | 3,591 | M | 61 | 12 | -3 | 7 | 18 | 11 | 0 | -8 | 0 | -5 | -10 | -82 | -68 | -77 |
6/21/13 16:19 | 6/19/13 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Berger Harvey J M D | MA | DO | CB,CEO | S | -202 | 18.00 | 33 | -11 | 0 | 3,752 | M | 80 | -5 | -17 | -15 | 1 | -9 | -12 | -6 | -2 | 5 | 16 | 29 | -70 | -60 |
5/16/13 16:38 | 5/14/13 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Berger Harvey J M D | MA | DO | CB,CEO | S.m | -1,674 | 18.10 | 33 | -92 | -2 | 3,763 | M | 86 | 1 | -19 | -15 | 0 | -5 | -1 | 5 | 1 | 11 | 9 | 11 | -82 | -58 |
4/22/13 17:07 | 4/17/13 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Berger Harvey J M D | MA | DO | CB,CEO | S | -1,898 | 18.01 | 33 | -105 | -3 | 3,919 | M | 133 | 28 | -23 | -9 | -12 | 2 | 3 | 5 | 1 | -2 | -10 | 8 | -75 | -59 |
3/14/13 16:33 | 3/12/13 | ARIA | Ariad Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Berger Harvey J M D | MA | DO | CB,CEO | S.m | -2,324 | 22.05 | 33 | -105 | -3 | 3,933 | M | 287 | 50 | 1 | -4 | 12 | 5 | 4 | 4 | -2 | -8 | -18 | -19 | -3 | -66 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |